Singapore: OxOnc Development, an oncology development company founded by pharmaceutical development executives and oncol...
Invivoscribe Technologies Inc., a US-based company with international experience in commercializing in-vitro diagnostic ...
Singapore: Medidata, a provider of cloud-based solutions for clinical research, has collaborated with Japan Pharmaceutic...
Singapore: Japan based Takeda Pharmaceutical has participated in WIPO Re:Search, a consortium to accelerate research and...
Singapore: CPhI Japan, organized by UBM EMEA, is set to begin at the Big Sight Exhibition Center, Tokyo, Japan, from Apr...
Singapore: Japan's Astellas Pharma and Potenza Therapeutics, a biotechnology company developing a portfolio of immuno-on...
Singapore: As part of expanding and strengthening its bioscience operations, Japan-based Tosoh Corporation has acquired ...
Singapore: Naviscan, the global leader in organ-specific molecular imaging, received Shonin approval from the Japanese M...
Tokyo: Japanese pharmaceutical giant, Daiichi Sankyo Company Limited has announced that its wholly-owned subsidiary in ...
Singapore: Chugai Pharmaceutical and US-based Athersys have entered into a partnership and license agreement to exclusiv...
The Sanford Consortium for Regenerative Medicine in La Jolla, California, and the Japanese major Takeda Pharmaceutical C...
Roche has announced that the company has entered into an agreement to develop a companion diagnostic (CDx) test for dalc...
Carna Biosciences has signed a worldwide licensing agreement with Janssen Biotech Inc., one of the Janssen Pharmaceutica...
Singapore: Millennium Research Group (MRG) estimates that transcatheter aortic valve replacement (TAVR) devices will be ...
Daiichi Sankyo Company Limited has initiated its Hokusai-VTE Cancer, a multinational study which will investigate the ef...
Tokyo: Australia's regenerative medicine company, Mesoblast Limited has announced that its allogeneic mesenchymal stem c...
Tokyo: Cambridge-based Syros Pharmaceuticals has entered into an exclusive license agreement with the Japanese oncology...
Singapore: Cellmid has signed an important option agreement with listed Japanese company Fujikura Kasei, a major suppli...
